Yangzhou MDL Industry Co., Ltd. was set up in 2006, in the historical city- Yangzhou.

With the idea of "people-oriented", MDL has been dedicated to the manufacture and distribution, research and development of safety medical device since 2009, protecting healthcare workers and patients from the risks associated with needle stick injury. Advanced humanistic cared concept, making MDL’s safety products widely appreciated all over the world. Products range from safety injection series, blood collection series, diabetes cares solutions, to safety infusion series.

MDL has a strong technical force, with a R&D center of 20 engineers and over 50 patents, including international invention patents for safety needles and safety retractable insulin syringes covering 48 countries.


MDL has been awarded as high-integrity enterprise for more than 10 years, and is honored as National High and New Tech Enterprise. The products has got the certificate of CE0197,ISO13485, INMETRO, FDA,KGMP, and CFDA. Through cooperation with famous customers, MDL improves SOP in order to meet with high-level markets' requirements.

MDL is on the way of innovation. In future, we will continuously protect the safety of healthcare workers, patients and the environment by providing innovative, high quality medical devices. Improve the products, and develop more and more new products for the markets.



To build MDL to be the lead manufactuer of safety vaccine syringes in the world. 


Your safety, Our care!













Passed CE0197 and ISO13485 audition in 2007;
Passed Brazil INMETRO audition in 2009 and got Australian TGA certificate in 2014;
Became the largest manufacturer of safety medical consumable products in China in 2016;
Passed the US FDA 510K audition in 2017;
Passed KGMP audition and obtained the CFDA Certificate for Safety Syringe (Needle) in 2018. ;
Became one of the first batch of provincial-level key production enterprises of epidemic prevention products in Jiangsu Province and included in the White List of Export Enterprises issued by the Ministry of Commerce in 2020;
Put the third plant into production successfully in July 2021, with the annual production capacity of safety syringes exceeding 2 billion pieces.;
Rated as a “Little Giant Enterprise”featuring specialization, refinement, differentiation, and innovation by the Ministry of Industry and Information Technology of the People's Republic of China and the Technology Research And Development Center for Safety Injection Engineering of Jiangsu Provincial Department of Science and Technology in August 2021;
Rated as a “Little Giant Enterprise” featuring specialization, refinement, differentiation, and innovation by the Ministry of Industry and Information Technology of the People’s Republic of China again in May 2022;
Rated as the Upgraded Enterprise Technology Center of Jiangsu Province in August 2022.
Why choose us?
100% Satisfaction


Technical Strength

MDL has a R&D center with 15 engineers and more than 40 patents, and keeps developing new products.


Quality Assurance

Having Achieved the ISO, CE, FDA and other international system certification, SOP guarantees eligible quality.


Global Market

MDL’s safety products well well in overseas markets such as the United States, Europe, South Korea, etc.

Business Philosophy

MDL always adheres to the mission of “Your Safety, Our Care”, the vision of Developing MDL into the world’s top production base of safety vaccine syringes, and the values of Seeking common development, win-win cooperation and co-creation together with customers.



In order to provide unconditional customer satisfaction; Delivering the products that our customers want, just as they desire, on time, is the main principle of our Quality Policy.